| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
McArdle Laboratory for Cancer Research, The Medical School, University of Wisconsin, Madison, Wisconsin 53706
Malignant transformation has been induced by N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) in synchronized cultures of the C3H/10T1/2 CL8 line of mouse fibroblasts. This transformation shows marked cell cycle dependency, with the sensitive phase for malignant transformation located somewhere between 4 hr prior to S and the G1-S boundary. Cells were synchronized by arginine or isoleucine deprivation for 48 hr, by 2 mM thymidine for 24 hr, or by release from postconfluence inhibition of cell division. Replicate cultures were treated with MNNG, 4 µg/ml, at various times prior to, at, or after release of the block. DNA synthesis began 4 hr after release of cells from arginine or isoleucine deprivation, and about 90% of the cells doubled after 10 to 14 hr. A peak in transformation frequency (TF) occurred at the time of release in arginine-deprived cells, and 4 hr after release of the block in isoleucine-deprived cells. Synchrony induced by 2 mM thymidine was poorly defined; DNA synthesis began within 2 hr and cell division began within 4 hr after removal of the thymidine. The peak in TF occurred at the time of release of the block. When cells were released from postconfluence inhibition of cell division, a peak of TF was observed 4 hr prior to S phase, and a second peak of TF was located shortly before the second round of DNA synthesis. MNNG killed 99.9% of cells at the time of maximal TF, and toxicity increased as cells entered S phase. Arginine deprivation did not cause an alteration in chromosome number. Morphologically transformed colonies from MNNG-treated dishes were cloned, cultured, and injected into X-irradiated syngeneic mice. Nine of 10 transformed lines gave sarcomas, but the untreated line did not.
1 This work was supported in part by Grant BC-2C from the American Cancer Society and Grant CA07175 from the National Cancer Institute, NIH. A preliminary account of this work has been presented (4).
2 Holder of a research training fellowship awarded by the International Agency for Research on Cancer, Lyon, France.
3 American Cancer Society Professor of Oncology.
Received 9/11/73. Accepted 12/ 3/73.
This article has been cited by other articles:
![]() |
W. Slikker III, N. Mei, and T. Chen N-Ethyl-N-nitrosourea (ENU) Increased Brain Mutations in Prenatal and Neonatal Mice but Not in the Adults Toxicol. Sci., September 1, 2004; 81(1): 112 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Lehane, P. E. Bryant, A. C. Riches, L. A. Allen, C. V. Briscoe, J. Melville, and A. J. Mill 238Pu {alpha}-particle-induced C3H10T½ transformants are less tumorigenic than the X-ray-induced equivalent Carcinogenesis, January 1, 1999; 20(1): 35 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Herschman and D. Brankow Ultraviolet irradiation transforms C3H10T1/2 cells to a unique, suppressible phenotype Science, December 12, 1986; 234(4782): 1385 - 1388. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |